[1]
D. Krupnik, “POTENTIAL USE OF GLP-1 RECEPTOR AGONISTS IN THE MANAGEMENT OF CHRONIC PAIN SYNDROMES: ANTI-INFLAMMATORY AND NEUROPROTECTIVE PERSPECTIVES”, IJITSS, vol. 5, no. 3(51), Sep. 2026, doi: 10.31435/ijitss.3(51).2026.6275.